Literature DB >> 10468010

Effect of rhesus rotavirus vaccine on enteric adenovirus--associated diarrhea in children.

X L Pang1, E Koskenniemi, J Joensuu, T Vesikari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468010     DOI: 10.1097/00005176-199909000-00026

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  5 in total

1.  Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination.

Authors:  Filemón Bucardo; Yaoska Reyes; Lennart Svensson; Johan Nordgren
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

2.  The effectiveness of rotavirus vaccine in preventing acute gastroenteritis during rotavirus seasons among Polish children.

Authors:  Dorota Mrozek-Budzyn; Agnieszka Kieltyka; Renata Majewska; Malgorzata Augustyniak
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

3.  Clinical profile of children with norovirus disease in rotavirus vaccine era.

Authors:  Mary E Wikswo; Rishi Desai; Kathryn M Edwards; Mary Allen Staat; Peter G Szilagyi; Geoffrey A Weinberg; Aaron T Curns; Benjamin Lopman; Jan Vinjé; Umesh D Parashar; Daniel C Payne; Aron J Hall
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

4.  Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.

Authors:  Susanne Hartwig; Matti Uhari; Marjo Renko; Perrine Bertet; Maria Hemming; Timo Vesikari
Journal:  BMC Health Serv Res       Date:  2014-12-11       Impact factor: 2.655

5.  Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.

Authors:  Maria Hemming; Sirpa Räsänen; Leena Huhti; Minna Paloniemi; Marjo Salminen; Timo Vesikari
Journal:  Eur J Pediatr       Date:  2013-01-30       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.